Literature DB >> 3025102

Anti-delta antibody in primary hepatocellular carcinoma patients in the Gizan area of Saudi Arabia.

S J Ashraf, S C Arya, C M Parande, R Sahay, A R Ageel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025102     DOI: 10.1007/BF01644273

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  5 in total

1.  Does delta infection play a part in the pathogenesis of hepatitis B virus related hepatocellular carcinoma?

Authors:  M C Kew; G M Dusheiko; S J Hadziyannis; A Patterson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-09

2.  Delta agent infection in patients with chronic liver diseases and hepatocellular carcinoma--an infrequent finding in Taiwan.

Authors:  D S Chen; M Y Lai; J L Sung
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

3.  Delta agent and hepatocellular carcinoma.

Authors:  A Craxì; G Raimondo; G Giannuoli; G Longo; M Caltagirone; M Aragona; G Squadrito; L Pagliaro
Journal:  Prog Clin Biol Res       Date:  1983

4.  Hepatitis B virus in Gizan, Saudi Arabia.

Authors:  S C Arya; S J Ashraf; C M Parande; M el-Sayed; R Sahay; A R Ageel; M S Tobeiqi
Journal:  J Med Virol       Date:  1985-11       Impact factor: 2.327

5.  Prevalence of delta antigen/antibody in B-viral-associated hepatocellular carcinoma.

Authors:  S Govindarajan; F J Hevia; R L Peters
Journal:  Cancer       Date:  1984-04-15       Impact factor: 6.860

  5 in total
  5 in total

1.  Concentrations of ofloxacin in serum and cerebrospinal fluid of patients without meningitis receiving the drug intravenously and orally.

Authors:  N Bitar; R Claes; P Van der Auwera
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

2.  Possible interaction of fluoroquinolones with the benzodiazepine-GABAA-receptor complex.

Authors:  E Unseld; G Ziegler; A Gemeinhardt; U Janssen; U Klotz
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

3.  Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin.

Authors:  R Nau; M Kinzig; T Dreyhaupt; H Kolenda; F Sörgel; H W Prange
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

Review 4.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

5.  Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis.

Authors:  Neda Amini; Seyed Moayed Alavian; Ali Kabir; Seyed Hossein Aalaei-Andabili; Seyed Yasser Saiedi Hosseini; Mario Rizzetto
Journal:  Hepat Mon       Date:  2013-01-06       Impact factor: 0.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.